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Abstract
Sera of IgA nephropathy (IgAN) patients and normal subjects were analysed
by two-dimensional (2-D) gel electrophoresis. Densitometric analysis of the
2-D gels of IgAN patients and normal subjects revealed that their protein
maps were comparable. There was no shift of pI values in the major ·-heavy
chain spots. However, the volume of the ·-heavy chain bands were differently
distributed. Distribution was significantly lower at the anionic region in IgAN
patients (mean anionic:cationic ratio of 1.184 B 0.311) as compared to nor-
mal healthy controls (mean anionic:cationic ratio of 2.139 B 0.538). Our data
are in support of the previously reported findings that IgA1 of IgAN patients
were lacking in sialic acid residues.
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Introduction
IgA nephropathy (IgAN), a disease of unknown etiolo-
gy, is characterised by the predominant deposition of
IgA1 in the renal mesangia of all the patients. Elevation of
the serum levels of IgA1, IgA1 immune complexes and
IgA1 rheumatoid factor was also detected in approximate-
ly half of the patients [1]. Several recent studies have asso-
ciated the etiopathogenicity of IgAN with abnormal
hinge-glycosylation of IgA1. The hinge region O-glycans
of IgA1 are involved in the asialoglycoprotein receptor-
mediated hepatic uptake mechanism [2]. In patients with
IgAN, it was postulated that defects in post-translational
O-glycosylation, or structural modification of the O-gly-
cans of IgA1, may subject the immunoglobulins to a
change in their pattern of clearance and their consequen-
tial deposition in the glomerular mesangium [3].
Among the reported abnormalities of O-linked carbo-
hydrate structures of IgA1 in IgAN patients were a general
decrease in terminal galactosylation of the hinge region
O-linked carbohydrate moieties [4, 5] and a significant
shift of monosialylation of Galß1-3GalNac of the O-gly-
cans to asialo-Galß1-3GalNac moieties [6, 7]. In addition,
the Ï-containing IgA1 of IgAN patients were shown to be
more negatively charged [8–11], and higher association of
Ï than Î light chains with IgA1 of IgAN patients has been
observed [12–14]. The unusually glycosylated IgA from
IgAN patients and IgA1 with modified O-glycan struc-
tures were also demonstrated to have increased binding to
mesangial cells [15, 16].
In the present study we analysed the ·-heavy chains of
IgAN patients and normal healthy controls by subjecting
their sera to high-resolution two-dimensional (2-D) elec-
trophoresis and computerised densitometry.
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Materials and Methods
Sera
Serum samples were obtained from IgAN outpatients (age range
22–58 years) of the University Hospital, Kuala Lumpur, and normal
healthy adult volunteers (age range 20–42 years). The subjects came
from different ethnic backgrounds (Malay, Chinese and Indian).
Six millilitres of blood were collected in LIP-VAC gel serum sepa-
rator (L.I.P., West Yorkshire, UK) tubes. The tubes were centrifuged
at 3,000 g for 10 min, and separated sera were collected and kept at
–20°C.
Lectin
Preparation of crude extract of champedak seed lectin was per-
formed as previously described [15]. The crude extract of lectin was
subjected to an immobilised galactose-Sepharose affinity chromatog-
raphy in 0.01 M phosphate buffer containing 0.15 M NaCl, pH 7.2
(PBS). Elution of champedak lectin-C was carried out by using 0.8 M
of D-galactose dissolved in PBS. The lectin was then exhaustively
dialysed against PBS.
Conjugation of champedak lectin-C to horseradish peroxidase
(HRP) was performed by incubation of the purified lectin with peri-
odate-activated HRP in sodium carbonate buffer (pH 9.5) for 2 h at
room temperature. The solution was stirred for another 2 h at 4 °C
upon addition of sodium borohydrate to reduce the remaining free
enzymes. The conjugated lectin was kept at 4°C in the presence of
60% (v/v) glycerol.
2-D Gel Electrophoresis
2-D gel electrophoresis was performed using the Multiphor II
Electrophoresis System based on the recommended method by Phar-
macia (Uppsala, Sweden). Pre-cast immobiline dry strips pH 4–7
(Pharmacia) were rehydrated overnight in solution consisting of 8 M
urea, 0.5% (v/v) Triton X-100, 0.5% (v/v) Pharmalyte 3–10 and
12 mM dithiothreithol (DTT). The strips were aligned in a tray that
was filled with silicon oil. Serum was diluted four times with sample
buffer consisting of 9 M urea, 60 mM DTT, 2% (v/v) Pharmalyte
3–10 and 0.5% (v/v) Triton X-100. Isoelectric focusing was per-
formed in 3 steps by varying the voltage as suggested by the manufac-
turer.
For the second dimension, the strips were incubated for 10 min in
equilibration solution consisting of 6 M urea, 1% (w/v) SDS and 30%
(v/v) glycerol dissolved in 0.05 M Tris-HCl (pH 6.8), in the presence
of 0.3 M DTT. This was followed by incubation in similar equilibra-
tion solution containing 50 mM iodoacetamide for another 10 min.
Strips were placed on a SDS-PAGE gradient gel 8–18 (Pharmacia)
and electrophoresed for 95 min. The gel was developed by staining
with Coomassie brilliant blue R-250 and dried. Calibration of the
isoelectric points (pI) of the gels was performed by using the 2-D
SDS-PAGE standards (Bio-Rad, Hercules, Calif., USA).
Western Blotting
NovaBlot Kit of Multiphor II Electrophoresis System (Pharma-
cia) was used for transferring the protein to nitrocellulose membrane
(0.2 Ìm). The unit was run at 0.8 mA/cm2 for 1 h. The nitrocellulose
was incubated in Tris-buffered saline (TBS, pH 7.5) in the presence
of 3% (w/v) bovine serum albumin for 1 h at room temperature. The
membrane was washed three times with TBS with 0.1% (v/v) tween-
20 (pH 7.5) and subsequently incubated in HRP-conjugate diluted/
dissolved in the same buffer (2,000 times dilution of anti-human IgA,
Binding Site, Birmingham, UK; or 2 mg/ml of champedak lectin-C)
for another 1 h. Development of the Western blot was performed
using 25 ng 3,3)-diaminobenzidine and 5 Ìl 30% (v/v) H2O2 in 50 ml
TBS. The reaction was stopped by washing the membrane with dis-
tilled water.
Data Analysis
Dried 2-D electrophoretic gels and Western blots were scanned
by using Model GS-690 Imaging Densitometer and analysed by using
the computerised Molecular Analyst densitometry software (Bio-
Rad, Hercules, Calif., USA). Distribution of specific regions of the
·-heavy chain band was analysed in terms of volume, i.e., optical
density !l area in square millimetres of region. The Mann-Whitney
U test was used for estimating statistical significance. A p value of
!0.05 was considered to be a significant difference.
Results
2-D Electrophoretic Analysis of Serum Samples
Complex protein maps showing hundreds of spots
were obtained when serum samples were analysed by
high-resolution 2-D gel electrophoresis with Coomassie
blue staining (fig. 1). Altogether, the 2-D separation analy-
sis was performed on sera of 12 normal subjects and 12
IgAN patients, and their Coomassie-stained gels were
scanned by using an imaging densitometer. Analysis of
the gels conducted by using the computerised Molecular
Analyst software failed to detect any significant difference
between the protein maps obtained from normal subjects
and IgAN patients.
To locate the position of the ·-heavy chain, the 2-D
gels were blotted onto a nitrocellulose membrane and
detected with enzyme-linked ·-heavy chain-specific anti-
human IgA (fig. 2). The ·-heavy chain band detected from
the Western blot analysis was divided into the anionic
(pI !5.6) and cationic (pI 15.6) regions according to pre-
viously adopted methods [8, 9, 11]. When compared with
the Coomassie-stained 2-D gels that were subjected to
densitometric scanning and analysis, it was obvious that
the Coomassie-stained 2-D separation was only capable of
resolving the anionic region of the ·-heavy chain band as
the cationic region of the band was superimposed with
several other protein spots.
Within the anionic region of the ·-heavy chain band,
five spots which vary in volume and could be clearly dis-
tinguished according to their charges were detected.
These were denoted as S1 (pI 5.05), S2 (pI 5.13), S3
(pI 5.25), S4 (pI 5.35), and S5 (pI 5.49), respectively, from
acidic to basic sides of the gel. For comparative purposes
the anionic region of ·-heavy chain band was further
divided into the acidic (pI !5.25) and basic (pI 15.25)
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Fig. 1. High resolution 2-D electropho-
retic map of human serum. a Normal sub-
ject. b IgAN patient. Gels were stained with
Coomassie blue. The major anionic ·-heavy
chain spots were enframed and denoted as
S1 (pI 5.05), S2 (pI 5.13), S3 (pI 5.25), S4 (pI
5.35), and S5 (pI 5.49) from the acidic to bas-
ic sides of the gel. The acid side on all gels
and blots is to the left and the relative molec-
ular mass declines from their top.
Fig. 2. Western blot analysis using anti-
serum. To determine the location of the ·-
heavy chains, 2-D gel of normal human se-
rum was blotted onto nitocellulose and de-
tected with the HRP-conjugated polyclonal
·-chain-specific, anti-human IgA. A dividing
pI of 5.6 was used to separate the anionic
and cationic regions of the band.
a
b
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sides. A dividing pI of 5.25 was chosen for its being in the
middle of the range. The ratio of volume contribution
of the acidic to basic sides of the anionic region of the
·-heavy chain band was subsequently calculated. Analysis
performed on serum samples of normal healthy subjects
(n = 12) and IgAN patients (n = 12) demonstrated that
there was no significant difference between their mean
ratio of volume distribution (fig. 3).
Champedak Lectin-C Western Blot Analysis
Since Coomassie-stained 2-D gels allowed limited den-
sitometric analysis of the ·-heavy chain band only to its
anionic region, we subjected the 2-D gels of sera of the
normal subjects and IgAN patients to Western blotting. In
this study we used enzyme-conjugated champedak
lectin-C, a lectin which has been shown to demonstrate
selective strong interaction with O-glycans of IgA1 [17,
18], to detect the ·-heavy chain band. Examples of the
2-D lectin-C-detected Western blots of sera of normal
controls and IgAN patients are shown in figure 4. Our
results demonstrate that champedak lectin-C was a better
and more sensitive detecting reagent for Western blotting
of the ·-heavy chain spots as compared to the ·-heavy
chain-specific anti-human IgA polyclonal antiserum that
was earlier used. The pI of the ·-heavy chain from IgAN
patients and healthy controls resolved by this method
Fig. 3. Mean acidic:basic ratio of the anionic region of the ·-
heavy chain from normal controls and IgAN patients. A mid-range pI
of 5.25 was used to divide the anionic region into its acidic and basic
sides. There was no significant difference between the mean ratio of
volume distribution of acidic:basic sides of the anionic region of the
·-heavy chains from normal controls (0.825 B 0.255) and IgAN
patients (0.820 B 0.133).
Fig. 4. Champedak lectin-C Western blot
analysis. 2-D gels were blotted onto nitocel-
lulose and detected with HRP-conjugated
champedak lectin-C. Since lectin-C inter-
acted with O-linked Galß1-3GalNAc carbo-
hydrate structures, other O-glycan-contain-
ing glycopeptides besides the ·-heavy chains
of IgA1 were also detected. Densitometric
analysis was, however, focused only on the
·-chain spots of IgA1 (enframed). Western
blot analysis was performed on the sera of a
normal subject (a) and an IgAN patient (b).
The anionic and cationic regions of the blot-
ted ·-heavy chains were separated at the
mid-range pI or 5.6.
a
b
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Fig. 5. Mean anionic:cationic ratio of the total ·-heavy chain
band from normal healthy controls and IgAN patients. A pI of 5.6
was used to divide the ·-heavy chain band into its anionic and cat-
ionic regions. The mean ratio of patients (1.184 B 0.311) was signifi-
cantly lower than normal healthy controls (2.139 B 0.538).
spanned from 4.4 to 6.8, a result which is compatible with
several previously reported studies on IgA [10–12].
By using the IgA1-binding lectin as probe, the ·-heavy
chain band was fully resolved without any interference of
the other serum proteins at its cationic region. It was thus
possible to analyse the ratio of the volume distribution of
the anionic:cationic region of the band using a pI of 5.6 as
the dividing point according to the previously reported
method [8, 9, 11]. Figure 5 demonstrates the data of anal-
ysis performed on the serum samples of normal subjects
(n = 10) and IgAN patients (n = 10). The mean an-
ionic:cationic ·-heavy chain volume distribution ratio
was significantly higher in normal healthy controls (2.139
B 0.538) than the mean ratio of IgAN patients (1.184 B
0.311).
Discussion
The main objective of this study was to compare IgAN
patients and normal healthy subjects by separation of
their serum proteins using high-resolution 2-D gel electro-
phoresis. The method provided better resolution of glyco-
proteins varying in charge distribution as compared to the
conventional isoelectric focusing in a single dimension.
Instead of staining the 2-D gels with silver as normally
done, Coomassie blue was used in this study. This was
because silver stain gave higher background which af-
fected the scanning process. Despite the sensitivity of sil-
ver in picking up a low concentration of proteins, the pat-
terns of the ·-heavy chain spots that were resolved in Coo-
massie-stained gels were similar and adequately intense
for analytical purposes.
Comparably similar protein maps were obtained from
the 2-D electrophoretic separation of sera of normal
healthy subjects and IgAN patients. Because of the pres-
ence of other proteins at the cationic region of the ·-heavy
chain band, direct densitometric analysis of the Coomas-
sie-stained gels was only made possible at the anionic
region (pI !5.6). Within this region, the ·-heavy chain
was clearly resolved into five separate spots in all sera that
were studied. There was no shift of pI values in the major
anionic ·-heavy chain spots of IgAN patients as compared
to normal controls.
Since the five major spots at the anionic region of the
·-chain band were clearly distinguishable in all sera that
were tested, an attempt was made to determine whether
there was a difference in the pattern of ·-heavy chain dis-
tribution among the spots obtained from healthy controls
and IgAN patients. The anionic region of the ·-heavy
chain band was thus further divided into the acidic and
basic sides using the mid-range pI of 5.25 as the dividing
factor. However, there was no significant difference be-
tween their mean ratio of volume distribution of
acidic:basic sides of the anionic region of the ·-heavy
chain bands of normal healthy controls and IgAN pa-
tients.
A more complete analysis of the 2-D gel separation of
sera of normal subjects and IgAN patients was made pos-
sible when the gels were Western-blotted onto a nitrocel-
lulose membrane and detected with an enzyme-conju-
gated IgA1-reactive champedak lectin-C. Since the West-
ern blots were no longer encumbered with the other serum
proteins at the cationic region of the ·-heavy chain band,
it was possible to obtain the anionic:cationic volume dis-
tribution ratio of the band. Analysis performed on sera of
IgAN patients (n = 10) demonstrated an anionic:cationic
·-heavy chain mean distribution ratio of 1.184 B 0.311,
which was significantly lower than the mean anionic:cat-
ionic ratio of 2.139 B 0.538 obtained from sera of normal
healthy subjects (n = 10).
The above differential charge distribution generally
imply that the ·-heavy chains of IgAN patients were more
cationic and thus lacking in sialic acid as compared to the
·-heavy chain of normal healthy controls. This is compat-
·-Heavy Chains of IgA Nephropathy
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ible with the recent report of Hiki et al. [7] which demon-
strated that the IgA1 of IgAN patients contained a rela-
tively higher concentration of asialo-Gal-GalNAc moie-
ties and was lacking in monosialo-Gal-GalNAc structures
when compared with the IgA1 from healthy controls. On
the other hand, studies by isoelectric focusing have also
demonstrated that the Ï-light chain containing IgA of
IgAN patients were more anionic [9–11]. The anionic
nature of intact whole IgA molecules may be attributed to
the presence of the Ï-light chains since Î-containing IgA1
were shown to be cationic in nature. In this study, we only
focused on the pI of the glycosylated ·-heavy chains
instead of the total intact IgA1 molecules.
The data of this study provide additional experimental
evidence to demonstrate the existence of carbohydrate
structural differences between IgA1 on IgAN patients and
normal subjects. The question of how these changes
would relate to the underlying pathogenesis of IgAN is
unclear. The unusual structure of the O-glycans of IgA1 in
IgAN patients may induce a conformational instability to
the IgA1 molecule as proposed by Hiki et al. [7], and/or
cause a glomerular accumulation of IgA1 as suggested by
Mestecky et al. [16]. The latter proposal was based on the
observation that modification of the structures of carbo-
hydrate moieties of IgA1 with neuraminidase and ß-galac-
tosidase caused a decrease in binding to the liver cells
but an increase in binding to the mesangial cells of the
kidney.
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